Long-acting Reversible Contraception (LARC) is a highly efficacious, safe and underutilized contraceptive method. Each year in the U.S., 43 million women are at risk for unplanned pregnancy. Increasing access to LARC can significantly decrease the rate of unplanned pregnancy, and especially for teens for whom timely point-of-care access can be critical. LARC is also the…
Due to AHP’s success in our most recent year’s value based contracts, we have the good fortune to have achieved significant shared savings. While the vast majority has been distributed back to our members as gain share, we felt it would be prudent to utilize a portion of this money to fund initiatives aimed at…
AHP’s Fall Clinical Grand Rounds is scheduled for Wednesday, November 7, 2018. The event will be held at the UR Alumni and Advancement Center, with registration from 5-5:30pm, presentations from 5:30-7:00pm, and networking directly following. The agenda for this Grand Rounds includes: Substance use disorder screening and prescribing Naloxone training Panel discussion on medication-assisted treatment…
Since its launch in March 2018, AHP’s Lead Testing Initiative has already shown promising results with six months of operation in practices across the network. Our goal for initiative is not only to improve lead screening rates but also to provide education and resources around early detection, intervention and monitoring of every child that has…
Many AHP primary care providers took part in the SPRINT initiative, which was a joint effort with the Finger Lakes Performing Provider System (FLPPS) to close gaps in care in the Medicaid population across 11 key metrics. Because of your efforts, between May 1st and July 1st, AHP PCPs closed 1,945 gaps in the Medicaid…
Market Share of ICS/LABA inhalers: In July, we refocused our inhaler initiative target, requesting that prescribers consider the use of either fluticasone/salmeterol RespiClick or Symbicort as “first line” in the ICS/LABA class. We set an achievable network goal based on your feedback to decrease Advair Diskus/HFA’s market share from 54% in 2017 to 41% by…
Highland Hospital’s Department of Family Medicine together with FLPPS is sponsoring a free course on the treatment of opioid use disorder. This course was designed by the American Society of Addiction Medicine and can be taken by any physician, nurse practitioner or physician assistant who works with patients with opioid use disorder and who wishes…
Arcadia-implemented practices (or those that will be implementing soon) are invited to join us for the Arcadia Quarterly Forum on Tuesday, September 11, 2018 from 12:15 pm to 1 pm. We will be discussing the impact to the dashboard from the recent Medent upgrade, the new care management platform and other topics including best practices…
We are pleased to announce that AHP earned significant gainsharing under our 2017 payer contracts, which we will soon be sharing with you, our network partners. Due to the efforts of AHP providers to deliver high-quality and efficient clinical care, our network succeeded in achieving outstanding performance on quality measures while creating value for the…
In this month’s population health report, AHP providers continue to deliver outstanding quality performance. The lead screening initiative that helps practices obtain lead testing equipment and integrate point-of-care testing into practice is contributing to the upward movement in the pediatrics preventive measure cohort. Questions about point-of-care lead testing? Contact Pediatric Quality Project Manager Meagan Fournier-Boome.
